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analysed for different diseases and 
sensitivity to medication. The results, 
which revealed risks of heart disease, 
diabetes and prostate cancer, could 
pave the way to similar tests for the 
general public.”
The Daily Mirror on the same day 
was equally succinct, but at the same 
time both more and less informative: 
“A scientist has become the first 
person in the world to have his DNA 
screened. In a study published in 
The Lancet Prof Stephen Quake, a 
bioengineer at Stanford University, 
California, was examined for 55 
conditions, ranging from type 2 
diabetes to schizophrenia. But in 
another article heart scientist Prof 
Nilesh Samani, of Leicester University, 
wrote of ethical issues — ‘who should 
have their genome sequenced, what 
counselling be provided and who 
should have access to an individual’s 
genetic information’”.
At the other extreme, The 
Independent allocated an entire page 
to a report on the scientific work plus 
a background commentary by science 
editor Jeremy Laurance. An excellent 
graphic highlighted nine different 
conditions, the risk in each case faced 
by Quake and the average risk for men 
of his age in the general population.  
For example, his risks of developing 
obesity, heart disease, diabetes and 
depression were 63%, 58%, 55% and 
25%, respectively, as compared with 
average figures of 25%, 50%, 27% 
and 10%.
Both the news report and 
commentary referred to wider 
aspects of the development and 
wider application of genome analysis. 
Laurance explained how it can 
provide information to help individuals 
live with increased susceptibility to 
particular maladies (as Quake has 
done by beginning to take statins to 
prevent cardiovascular disease). The 
new technique will also help doctors 
to encourage patients predisposed 
to lung cancer to stop smoking, and 
those prone to obesity or diabetes to 
moderate their diets. 
In other cases, Laurance pointed 
out, the provision of genetic 
information could be positively 
harmful, the only outcome being that 
an affected individual would have to 
live under the shadow of a threatened 
disease. “Analysis of your genome 
could reveal you were carrying a gene 
for Huntingdon’s disease, a condition 
that kills people in their 20s and for 
which there is no treatment. Would 
there be benefit in that?” 
Dwarfed by a headline “The DNA 
death test”, the Daily Mail carried 
a similar chart (with most of the 
percentages different from those 
in The Independent, but with the 
same general relative risks). Medical 
correspondent Jenny Hope pointed 
out that we are rapidly approaching 
an era when everyone will be able to 
have their DNA scanned for evidence 
of disease propensities. She said that 
tests already available commercially 
at around £300 can read part of a 
person’s genome, and that others 
costing $2,000 (£1,300) give verdicts 
on the risks of 50 common diseases.
“Cardiologist Euen Ashley, one 
of the Stanford scientists, said the 
falling cost of genome sequencing 
would soon put screening of the 
full code within reach of the general 
public.” The $1,000 (£657) genome 
was coming fast. The challenge was 
in knowing what to do with all that 
information.
“Professor Henry Greely, from 
Stanford Law School, said patients, 
doctors and geneticists are about to 
be hit by a ‘tsunami’ of genetic data. 
‘We predict that an average person 
might need information about roughly 
100 genetic risks,’ he said. He warned 
that it would take at least five hours 
to counsel the average patient about 
their genetic risks of disease, in 
addition to many hours of analysis to 
assess the nature of the risks.”
The Guardian did most to 
explain the science behind the 
announcement. “The scientists began 
by building a data-base of gene 
variants and their links to medical 
conditions,” science correspondent 
Ian Sample wrote. “Atul Butte, who 
worked on the study, said: ‘We read 
thousands of publications and made a 
list of every single spot in the genome 
where we know that, for example, the 
letter A raises the risk of a particular 
disease, or the letter T confers 
protection.’” Although news editors 
had dramatically different feelings 
about the importance of this story, 
those who did cover it were united 
in one thing. None of them invoked 
those ethicists and commentators 
who can be relied upon to voice dire 
warnings about most advances in 
biomedicine. Good.
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American Society for Microbiology.For the first time in more than 30 
years, the outcome of Britain’s general 
election earlier this month failed to 
deliver an outright victory to one party 
and a liberal – conservative coalition 
has emerged. Europe is in the grip of 
debt troubles and voters may have 
been unsure of who may be best at 
handling the problem.
While eyes have been focused on 
Greece and the enormous bail-out 
loans agreed by other European states 
to help the country prevent defaulting 
on its debt, other commentators 
pointed out that the UK’s budget 
deficit is far larger than that of Greece.
On the eve of the election the 
European Commission predicted that 
the British deficit for this calendar 
year would be 12 per cent of GDP, the 
highest of all the 27 EU nations. The 
country’s budget shortfall was the 
third largest in the EU last year but is 
now set to overtake both Greece and 
Ireland. Greece’s painful measures, 
which have sparked so much protest, 
are estimated to reduce its deficit to 
9.3 per cent of GDP.
With such a serious budget shortfall 
facing the new British government, 
it is inevitable that science, higher 
education and health will face their 
share of wider cutbacks.
Indeed, The Times reported the 
governor of the Bank of England, 
Mervyn King, saying before the election 
that the austerity measures needed to 
tackle Britain’s budget deficit would 
be so unpopular that whoever won 
the election would not get back into 
government for a generation.
Science has generally fared 
quite well under the last Labour 
government, but the mood had 
begun to change in recent years as 
the budget problems loomed. The 
government’s pre- budget report in 
December last year announced that 
£600 million would be cut from higher 
education and science and research 
budgets by 2012–13.
The prospect of budget cuts 
prompted the House of Commons 
science and technology committee to 
launch an enquiry earlier this year to 
examine likely impacts. 
Science and health will not be immune 
from the deep spending cuts the 
new British government must now 
implement. Nigel Williams reports.
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and Liberal Democrat parties, at the 
meeting, said they had no plans to cut 
the 2010–11 science budget.
Science funding has supposedly 
been within a ring fence over recent 
years but the current situation is 
due to expire in this financial year. 
Afriyie said the Conservatives were 
committed to allocating a “multi-year 
ring-fenced science budget”.
But some researchers remain worried 
about Conservative plans. In a letter to 
The Independent last month a group 
of researchers including senior figures 
such as Sir Paul Nurse, virologist Robin 
Weiss and physicist Ken Pounds 
highlighted earlier comments that the 
Conservatives were a “vision-free zone” 
and “their continuing failure to address 
this critique is making us concerned that 
this lack of vision actually reflects a lack 
of commitment. Our economic recovery 
depends on sustaining and utilising 
Britain’s position in global science.”
But on the eve of the election, 
lecturers from 14 universities and 
colleges staged a one-day strike in 
protest over cuts. The University and 
College Union, which organised the 
protest, said that English universities 
face funding cuts of 1.1 per cent 
although they are receiving record 
numbers of applications for courses – 
16.5 per cent up compared with last 
year.
And the National Health Service, 
which also carries out substantial 
amounts of research and assessment 
of new treatments, is braced for cuts.
The Times reported that the number 
of health bodies seeking advice for big 
changes, including possible closures, 
had doubled over the past year.
Experts suggest that the NHS will 
be structured around fewer, larger 
hubs of specialist services with 
many more ‘outreach’ units in local 
communites in a move away from the 
district-hospital model at present. 
Regardless of the shape of Britain’s 
new government, if Mervyn King is 
to be believed, science, health and 
higher education funding is, indeed, 
set for troubled times.
In its report, published in March, 
it concluded that the government 
should “commit to an increase in 
investment in science now or risk 
devastating British science and the 
economy in years to come.”
But such pleas are likely to make 
little impact on the realities facing the 
new government. Before the election, 
the lobby group Campaign for Science 
and Engineering in the UK (CASE) 
had questioned the three main parties 
on science policy. Adam Afriyie, the 
Conservative shadow minister for 
innovation, universities and skills, said: 
“Our science base is a valuable national 
assest. Economically, politically and 
socially, it underpins the prosperity and 
well-being of our nation.”
But in comments reported in the 
Times Higher Education, Afriyie, 
speaking at a cross-party debate on 
science in London, said that he would 
‘hold a party’ if the Conservatives  
managed to maintain spending in 
the short term. “These are troubled 
times,” he said. Both the Labour 
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